Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

80.30p
   
  • Change Today:
    -3.80p
  • 52 Week High: 159.80
  • 52 Week Low: 67.00
  • Currency: UK Pounds
  • Shares Issued: 961.97m
  • Volume: 868,674
  • Market Cap: £772.46m

Dr Martens appoints Giles Wilson as CFO

By Michele Maatouk

Date: Tuesday 14 Nov 2023

LONDON (ShareCast) - (Sharecast News) - Iconic bootmaker Dr Martens said on Tuesday that it has appointed Giles Wilson as chief financial officer.
Wilson will take up his new role next year, with the date to be confirmed and announced "in due course".

The experienced CFO joins Dr Martens from spirits company William Grant & Sons Limited, which owns premium brands including Glenfiddich Scotch Whisky, The Balvenie Whisky and Hendrick's Gin. Prior to this, Wilson was at John Menzies as CFO between 2016 and 2020, and then subsequently became CEO from 2019 to 2020.

He qualified as a chartered accountant with PwC and previously held a senior role at Commercial Estates Group.

Chair Paul Mason said: "Following a rigorous selection process, we are delighted to appoint Giles as CFO. He is a very capable finance leader with extensive experience in a number of sectors and, most recently, his time in the branded spirits industry has given him a good grounding in global brands and wholesale distribution management.

"His knowledge of the public markets will be a valuable asset to the team as Dr Martens continues its growth in the listed environment. I look forward to him joining the board."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 80.30p
Change Today -3.80p
% Change -4.52 %
52 Week High 159.80
52 Week Low 67.00
Volume 868,674
Shares Issued 961.97m
Market Cap £772.46m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.00% above the market average30.00% above the market average30.00% above the market average30.00% above the market average30.00% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
72.01% below the market average72.01% below the market average72.01% below the market average72.01% below the market average72.01% below the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average
Income
36.95% above the market average36.95% above the market average36.95% above the market average36.95% above the market average36.95% above the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
92.57% below the market average92.57% below the market average92.57% below the market average92.57% below the market average92.57% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 29-Aug-24 04-Jan-24
Paid 01-Oct-24 02-Feb-24
Amount 0.99p 1.56p

Trades for 14-Jun-2024

Time Volume / Share Price
16:35 7,766 @ 80.30p
16:35 350,567 @ 80.30p
16:35 700 @ 80.30p
16:35 1,387 @ 80.30p
16:35 335 @ 80.30p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson
CFO Giles Wilson

Top of Page